Colorectal Cancer :: Cetuximab and irinotecan combination increases survival in colorectal cancer patients
A phase III trial of 1,298 colorectal cancer patients has found that a combination of the drugs cetuximab (Erbitux) and irinotecan showed a significant improvement in progression-free survival over just irinotecan alone, according to an international team of researchers.